Guanhao Biotech Co.,Ltd. (SHE:300238)
China · Delayed Price · Currency is CNY 15.65
+0.04 (0.26%)
Feb 13, 2026, 3:04 PM CST
Guanhao Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 26.3 | 27.42 | 31.01 | -307.82 | 73.69 | 46.59 |
Depreciation & Amortization | 26.61 | 26.61 | 29.01 | 33.04 | 38.8 | 28.18 |
Other Amortization | 1.26 | 1.26 | 5.96 | 8.09 | 11.03 | 6.83 |
Loss (Gain) From Sale of Assets | -0.03 | -0.03 | -0.92 | -0.03 | -0.33 | 0.01 |
Asset Writedown & Restructuring Costs | 4.98 | 4.98 | 0.29 | 217.94 | 0.19 | 0.04 |
Loss (Gain) From Sale of Investments | 10.23 | 10.23 | 3.64 | 41.36 | 4.68 | 3.14 |
Provision & Write-off of Bad Debts | 8.56 | 8.56 | 6.72 | 8.91 | 2.7 | 2.66 |
Other Operating Activities | 12.51 | -8.9 | 2.93 | 52.99 | -6.22 | 17.21 |
Change in Accounts Receivable | 19.96 | 19.96 | 11.12 | 40.05 | 14.17 | 9.87 |
Change in Inventory | -2.13 | -2.13 | -5.84 | 9.2 | -14.98 | -31.41 |
Change in Accounts Payable | -36.83 | -36.83 | -27.87 | -54.31 | -15.12 | 21.64 |
Operating Cash Flow | 69.85 | 49.55 | 54.15 | 70.98 | 122.39 | 103.84 |
Operating Cash Flow Growth | 162.64% | -8.49% | -23.71% | -42.00% | 17.87% | 12.20% |
Capital Expenditures | -51.86 | -76.2 | -53.92 | -41.17 | -4.71 | -2.9 |
Sale of Property, Plant & Equipment | 0.11 | 0.1 | 0.01 | 0.03 | 5.03 | 0.02 |
Cash Acquisitions | -0.66 | -3.56 | - | - | -0.15 | - |
Divestitures | - | - | 2.8 | -0.77 | -0.13 | 0.26 |
Investment in Securities | -2.28 | -5.28 | - | 1.89 | 2.66 | -9.99 |
Other Investing Activities | -1.16 | - | - | - | - | - |
Investing Cash Flow | -55.85 | -84.95 | -51.11 | -40.02 | 2.7 | -12.61 |
Short-Term Debt Issued | - | - | - | - | 52 | - |
Long-Term Debt Issued | - | 85 | 37.5 | 50 | - | 158 |
Total Debt Issued | 48.95 | 85 | 37.5 | 50 | 52 | 158 |
Short-Term Debt Repaid | - | - | - | - | -153.25 | - |
Long-Term Debt Repaid | - | -38.94 | -63.62 | -116.97 | -13.05 | -218.25 |
Total Debt Repaid | -29.14 | -38.94 | -63.62 | -116.97 | -166.3 | -218.25 |
Net Debt Issued (Repaid) | 19.81 | 46.06 | -26.12 | -66.97 | -114.3 | -60.25 |
Common Dividends Paid | -3.59 | -2.46 | -1.21 | -3.68 | -6.97 | -14.17 |
Other Financing Activities | 6.77 | - | - | - | -0.5 | - |
Financing Cash Flow | 22.99 | 43.59 | -27.32 | -70.65 | -121.78 | -74.42 |
Foreign Exchange Rate Adjustments | 0.1 | 0.18 | 0.08 | 0.69 | -0.21 | -0.18 |
Net Cash Flow | 37.09 | 8.38 | -24.21 | -38.99 | 3.11 | 16.63 |
Free Cash Flow | 17.99 | -26.65 | 0.23 | 29.81 | 117.68 | 100.94 |
Free Cash Flow Growth | - | - | -99.22% | -74.67% | 16.59% | 17.07% |
Free Cash Flow Margin | 4.58% | -7.06% | 0.06% | 7.90% | 24.07% | 23.10% |
Free Cash Flow Per Share | 0.07 | -0.10 | 0.00 | 0.11 | 0.45 | 0.39 |
Cash Income Tax Paid | 46.45 | 38.77 | 46.56 | 39.93 | 30.81 | 26.26 |
Levered Free Cash Flow | 5.28 | -13.68 | 24.86 | 52.4 | 85.69 | 84.48 |
Unlevered Free Cash Flow | 7.39 | -13.03 | 25.97 | 54.97 | 90.3 | 93.59 |
Change in Working Capital | -20.57 | -20.57 | -24.47 | 16.49 | -2.15 | -0.82 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.